Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Medtronic plc

Now is a Great Time to Pick Up This Passive Income Stock

The surging inflation and the Fed’s efforts to tame it by aggressively hiking interest rates have led to many analysts forecasting a recession later this year. Investors must consider picking up stocks that generate passive income in an uncertain economic environment. Medtronic (MDT) recently announced an 8% increase in its…

5 All-Weather Stocks to Protect Your Portfolio from a Bear Market

5 All-Weather Stocks to Protect Your Portfolio from a Bear Market

In the current, uncertain market environment, one of the best strategies to protect one’s portfolio is to invest in stocks capable of withstanding all market and economic conditions. With fears of a looming recession, we think investors could look to add the stocks of all-weather companies Constellation Brands (STZ), Johnson…

Medtronic, DaVita To Jointly Form Kidney Health-Focused Company

Medtronic, DaVita To Jointly Form Kidney Health-Focused Company

Medtronic plc (NYSE:MDT) and DaVita Inc (NYSE:DVA) intend to form a new, independent kidney care-focused medical device company (NewCo). NewCo will focus on developing a broad suite of novel kidney care products and solutions, including future home-based products. Medtronic and DaVita will co-own the NewCo, each with equal equity stakes and led by an…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Why Medtronic Shares Are Plunging Today?

Medtronic Plc's (NYSE:MDT) Q4 FY22 sales of $8.09 billion decreased 1% Y/Y on a reported basis but increased 1% organically, missing the consensus of $8.42 billion. The company has forecasted Q4 organic revenue growth of approximately 5.5%. Q4 adjusted EPS of $1.52 increased 2%, missing the analyst consensus of $1.56. Medtronic's heart device…

2 Wide-Moat Stocks to Add to Your Portfolio Right Now

The major stock market indexes surged yesterday after the Fed Reserve raised benchmark interest rates by half a percentage point. However, the stock market is expected to remain under pressure at least in the near term on continuing macroeconomic and geopolitical concerns. So, we think it could be wise to…

Acutus Medical Stock Soars On Debt Refinancing, Divestiture Of Left-Heart Access Portfolio

Acutus Medical Inc (NASDAQ:AFIB) shares are skyrocketing on a commitment letter from Deerfield Management Company to refinance its existing debt with a new longer-term credit facility. The Company has also agreed to sell its left-heart access portfolio to Medtronic plc (NYSE:MDT). The combination of these two transactions, taken together with the Company’s recently completed restructuring,…

Medtronic Recalls Harmony Delivery Catheter Due Risk Of Breaking While Procedure

Medtronic Plc (NYSE:MDT) is recalling the Harmony Delivery Catheter, part of the Transcatheter Pulmonary Valve (TPV), due to the possibility that the bond holding the capsule at the end of the delivery catheter may break during a procedure. Harmony TPV System is used to treat a leaky native or surgically repaired right…

inkl

Read news from The Economist, FT, and more,
with one subscription

Medtronic's Portfolio Management Unlikely To Be A 'Magic Bullet,' Says Needham

Medtronic's Portfolio Management Unlikely To Be A 'Magic Bullet,' Says Needham

Needham published a report that pointed to previous comments from Medtronic plc's (NYSE: MDT) management that indicate the potential for changes in the coming year, with a spinoff of a large business considered an option.

Medtronic's US Trial Of GI Genius Endoscopy Module Reduces Missed Colorectal Polyps By 50%

Medtronic's US Trial Of GI Genius Endoscopy Module Reduces Missed Colorectal Polyps By 50%

Medtronic plc (NYSE:MDT) announced final findings from a study that confirmed the effectiveness of the GI Genius intelligent endoscopy module. GI Genius uses AI to aid in detecting colorectal polyps during colonoscopy, potentially helping to prevent colorectal cancer (CRC). The study published in Gastroenterology found that the use of GI Genius in conjunction with…

FDA Approves Medtronic's Recharge-Free Sacral Nerve Stimulation Therapy For Bladder, Bowel Control

FDA Approves Medtronic's Recharge-Free Sacral Nerve Stimulation Therapy For Bladder, Bowel Control

The FDA has approved Medtronic plc's (NYSE:

10 Biggest Price Target Changes For Tuesday

10 Biggest Price Target Changes For Tuesday

Needham cut Medtronic plc (NYSE: MDT) price target from $131 to $128. Medtronic shares fell 0.7% to $103.44 in pre-market trading.

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Constellation Brands

Sysco Corporation

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play